Mersana Therapeutics
MRSN
MRSN
128 hedge funds and large institutions have $322M invested in Mersana Therapeutics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 49 increasing their positions, 38 reducing their positions, and 15 closing their positions.
Holders
128
Holders Change
+6
Holders Change %
+4.92%
% of All Funds
2.03%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
21
Increased
49
Reduced
38
Closed
15
Calls
$42K
Puts
$372K
Net Calls
-$330K
Net Calls Change
+$608K
Top Buyers
1 |
1
Millennium Management
New York
|
$19.5M |
2 |
O
2
OrbiMed
New York
|
$19.1M |
3 |
3
D.E. Shaw & Co
New York
|
$8.34M |
4 |
4
Bank of Montreal
Toronto,
Ontario, Canada
|
$4.67M |
5 |
BCLSI
5
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$26M |